Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HEH8
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 3 |
GO:0003746 | translation elongation factor activity | 4 | 3 |
GO:0005488 | binding | 1 | 3 |
GO:0008135 | translation factor activity, RNA binding | 3 | 3 |
GO:0045182 | translation regulator activity | 1 | 3 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.460 |
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.255 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.552 |
CLV_PCSK_KEX2_1 | 56 | 58 | PF00082 | 0.303 |
CLV_PCSK_PC1ET2_1 | 56 | 58 | PF00082 | 0.250 |
CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.253 |
CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.389 |
CLV_PCSK_SKI1_1 | 89 | 93 | PF00082 | 0.242 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.447 |
DOC_CYCLIN_RxL_1 | 103 | 115 | PF00134 | 0.351 |
DOC_MAPK_FxFP_2 | 122 | 125 | PF00069 | 0.338 |
DOC_MAPK_gen_1 | 103 | 111 | PF00069 | 0.356 |
DOC_MAPK_gen_1 | 45 | 54 | PF00069 | 0.442 |
DOC_MAPK_MEF2A_6 | 103 | 111 | PF00069 | 0.356 |
DOC_MAPK_MEF2A_6 | 45 | 54 | PF00069 | 0.473 |
DOC_MAPK_NFAT4_5 | 47 | 55 | PF00069 | 0.455 |
DOC_PP1_RVXF_1 | 106 | 112 | PF00149 | 0.348 |
DOC_PP4_FxxP_1 | 122 | 125 | PF00568 | 0.338 |
DOC_USP7_MATH_1 | 138 | 142 | PF00917 | 0.421 |
DOC_USP7_UBL2_3 | 191 | 195 | PF12436 | 0.390 |
DOC_USP7_UBL2_3 | 219 | 223 | PF12436 | 0.374 |
DOC_WW_Pin1_4 | 125 | 130 | PF00397 | 0.549 |
DOC_WW_Pin1_4 | 29 | 34 | PF00397 | 0.490 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.696 |
LIG_FHA_1 | 185 | 191 | PF00498 | 0.335 |
LIG_FHA_1 | 203 | 209 | PF00498 | 0.491 |
LIG_FHA_2 | 165 | 171 | PF00498 | 0.376 |
LIG_LIR_Gen_1 | 116 | 126 | PF02991 | 0.379 |
LIG_LIR_Gen_1 | 170 | 178 | PF02991 | 0.396 |
LIG_LIR_Gen_1 | 98 | 107 | PF02991 | 0.388 |
LIG_LIR_Nem_3 | 116 | 122 | PF02991 | 0.498 |
LIG_LIR_Nem_3 | 170 | 175 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 98 | 102 | PF02991 | 0.407 |
LIG_SH2_CRK | 59 | 63 | PF00017 | 0.455 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.340 |
LIG_SH3_3 | 120 | 126 | PF00018 | 0.379 |
LIG_SH3_3 | 132 | 138 | PF00018 | 0.463 |
LIG_SH3_3 | 20 | 26 | PF00018 | 0.701 |
LIG_SH3_3 | 218 | 224 | PF00018 | 0.443 |
LIG_SUMO_SIM_par_1 | 203 | 210 | PF11976 | 0.411 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.424 |
MOD_CK2_1 | 164 | 170 | PF00069 | 0.415 |
MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.364 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.765 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.368 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.449 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.651 |
MOD_GSK3_1 | 5 | 12 | PF00069 | 0.706 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.473 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.328 |
MOD_PIKK_1 | 33 | 39 | PF00454 | 0.644 |
MOD_PIKK_1 | 64 | 70 | PF00454 | 0.442 |
MOD_Plk_1 | 173 | 179 | PF00069 | 0.479 |
MOD_Plk_2-3 | 164 | 170 | PF00069 | 0.371 |
MOD_Plk_4 | 177 | 183 | PF00069 | 0.489 |
MOD_ProDKin_1 | 125 | 131 | PF00069 | 0.551 |
MOD_ProDKin_1 | 29 | 35 | PF00069 | 0.490 |
TRG_DiLeu_BaEn_1 | 105 | 110 | PF01217 | 0.355 |
TRG_DiLeu_BaLyEn_6 | 30 | 35 | PF01217 | 0.494 |
TRG_DiLeu_LyEn_5 | 105 | 110 | PF01217 | 0.355 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.471 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.465 |
TRG_ER_diArg_1 | 106 | 109 | PF00400 | 0.353 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PFC1 | Leptomonas seymouri | 88% | 99% |
A0A0S4IL43 | Bodo saltans | 73% | 96% |
A0A1X0NYW1 | Trypanosomatidae | 76% | 100% |
A0A3R7KDV7 | Trypanosoma rangeli | 76% | 100% |
A0A3S7WZ68 | Leishmania donovani | 89% | 100% |
A4I1L2 | Leishmania infantum | 89% | 100% |
C9ZK54 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 76% | 100% |
E9AXP6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q9S5 | Leishmania major | 89% | 99% |